The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years

Eye

Volumn 25, Issue 6, 2011, Pages 740-745

  Malik, A N J ^a   Morris, R W ^b   Ffytche, T J ^c  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

leprosy; ocular complications; prevalence; risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CHILD; CORNEA DISEASE; CORNEA OPACITY; DISEASE SEVERITY; EYE DISEASE; EYELID DISEASE; FEMALE; HUMAN; IRIS ATROPHY; IRIS DISEASE; IRITIS; LAGOPHTHALMOS; LENS DISEASE; LEPROSY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SCLERA DISEASE; UNITED KINGDOM; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 79958696332     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.43     Document Type: Article

References (29)

1. Organisation WH. Factsheet number 101. http://www.who.int/mediacentre/ factsheets/fs101/en/, 2005.
2. WHO. Report of the global forum on elimination of leprosy as a public health problem. Access at http://whqlibdoc.who.int/hq/2006/WHO-CDS-NTD-2006.4- eng.pdf.
3. Bull OB, Hansen GA. The Leprous Diseases of the Eye. Albert Cammermeyer: Christiania, 1873.
4. Prasad VN, Narain M, Mukhija RD, Bist HK, Khan MM. A study of ocular complications in leprosy. Indian J Lepr 1984;56(2):241-250. (Pubitemid 14042540)
5. Reddy SC, Raju BD, Achary NR. Survey of eye complications in leprosy in Prakasam district (Andhra Pradesh). Lepr India 1981;53(2):231-237.
6. Malla OK, Brandt F, Anten JG. Ocular findings in leprosy patients in an institution in Nepal (Khokana). Br J Ophthalmol 1981;65(4):226-230. (Pubitemid 11066925)
7. ffytche TJ, Brandt F, Cerchez J, Stoicescu S, Stingl P, Filitis M. Ocular complications observed in leprosy patients in Romania. BMJ (Clinical Research Ed) 1992;305(6847):240-242.
8. ffytche TJ. The American Peace Corps Survey of the ocular complications of leprosy in South Korea: an evaluation and appraisal. Lepr Rev 1984;55(3):239-246. (Pubitemid 14025025)
9. Dethlefs R. Prevalence of ocular manifestations of leprosy in Port Moresby, Papua New Guinea. Br J Ophthalmol 1981;65(4):223-225. (Pubitemid 11066924)
10. Ticho U, Sira IB. Ocular leprosy in Malawi. Clinical and therapeutic survey of 8, 325 leprosy patients. Br J Ophthalmol 1970;54(2):107-112.
11. Courtright PD. Defining the magnitude of ocular complications from leprosy: problems of methodology. Int J Lepr Other Mycobact Dis 1988;56(4):566-573. (Pubitemid 19072864)
12. Daniel E, Koshy S, Rao GS, Rao PS. Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort. Br J Ophthalmol 2002;86(12):1336-1340. (Pubitemid 35408630)
13. Lewallen S, Tungpakorn NC, Kim SH, Courtright P. Progression of eye disease in 'cured' leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eyecare needs. Br J Ophthalmol 2000;84(8):817-821. (Pubitemid 30599083)
14. Daniel E, ffytche TJ, Kempen JH, Rao PS, Diener-West M, Courtright P. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy. Br J Ophthalmol 2006;90(8):949-954. (Pubitemid 44140168)
15. ffytche TJ. Residual sight-threatening lesions in leprosy patients completing multidrug therapy and sulphone monotherapy. Lepr Rev 1991;62(1):35-43.
16. Northern Advocate. Leprosy in London, Newspaper article 1906.
17. Editor. Leprosy in London. BMJ 1913;2(2761):1449.
18. Dana MHM, Viana MAG, Hill CH, Sugar J. Ocular manifestations of leprosy in a noninstitutionalised community in the United States. Arch Ophthalmol 1994;112:626-629. (Pubitemid 24155435)
19. Spaide R, Nattis R, Lipka A, D'Amico R. Ocular findings in leprosy in the United States. Am J Ophthalmol 1985;100(3):411-416. (Pubitemid 15240649)
20. Hogeweg M, Leiker DL. A survey on eye involvement among leprosy patients in The Netherlands. Doc Ophthalmol 1983;56(1-2):69-76. (Pubitemid 14199871)
21. ffytche TJ. A computer form to aid in the collection of data on the ocular complications of leprosy. Lepr Rev 1983;54(4):271-281. (Pubitemid 14152046)
22. Morris R. Bilateral procedures in randomised controlled trials. J Bone Joint Surg Br 1993;75(5):675-676. (Pubitemid 23267925)
23. Murdoch I. People and eyes: statistics in ophthalmology. Community Eye Health 1998;11(27):43.
24. Courtright P, Daniel E, Rao PS, Ravanes J, Mengistu F, Belachew M et al. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Lepr Rev 2002;73(3):225-238.
25. Thompson KJ, Allardice GM, Babu GR, Roberts H, Kerketta W, Kerketta A. Patterns of ocular morbidity and blindness in leprosy-a three centre study in Eastern India. Lepr Rev 2006;77(2):130-140. (Pubitemid 44076491)
26. Nepal BP, Shrestha UD. Ocular findings in leprosy patients in Nepal in the era of multidrug therapy. Am J Ophthalmol 2004;137(5):888-892. (Pubitemid 38582042)
27. Daniel E, ffytche TJ, Rao PS, Kempen JH, Diener-West M, Courtright P. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy. Br J Ophthalmol 2006;90(5):568-573.
28. ffytche TJ. The prevalence of disabling ocular complications of leprosy: a global study. Indian J Lepr 1998;70(1):49-59. (Pubitemid 28234247)
29. Lockwood D, Reid A. The diagnosis of leprosy is delayed in the United Kingdom. QJM 2001;94(4):207-212. (Pubitemid 32331640)